In addition, while our methylation sequencing data provided insight into FGF5 expression in methylation and its potential significance in tumor progression and treatment resistance, the limited number of samples from patients who relapsed after radiotherapy limited our ability to draw definitive conclusions about the association between FGF5 expression, methylation changes, and clinical outcomes. The gene discussed is FGF5; the disease is neoplasm.